
Sotera Health Company
Sotera Health Company(SHC)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · SHC · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
14
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Sotera Health Company内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
SHC 季度内部人买卖趋势
SHC 内幕交易卖出 · SHC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · SHC CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
SHC 高管卖出股份 · SHC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 26, 2026 | SHADER ALTON CEO · Director | Award | 203,634 | — | Form 4 |
| Mar 2, 2026 | Petras Michael B. Jr. Chairman & CEO · Director | Award | 240,248 | — | Form 4 |
| Mar 2, 2026 | Petras Michael B. Jr. Chairman & CEO · Director | Option | 89,686 | — | Form 4 |
| Mar 2, 2026 | Petras Michael B. Jr. Chairman & CEO · Director | Other | 39,552 | $629K | Form 4 |
| Mar 2, 2026 | Petras Michael B. Jr. Chairman & CEO · Director | Other | 40,302 | $641K | Form 4 |
| Mar 2, 2026 | Petras Michael B. Jr. Chairman & CEO · Director | Other | 79,104 | $1.26M⚡ | Form 4 |
| Mar 2, 2026 | DIMITRIEF ALEXANDER SVP, General Counsel and Sec. | Option | 16,816 | — | Form 4 |
| Mar 2, 2026 | DIMITRIEF ALEXANDER SVP, General Counsel and Sec. | Other | 23,619 | $376K | Form 4 |
| Mar 2, 2026 | Lyons Jonathan M. Sr. Vice President, CFO | Award | 59,355 | — | Form 4 |
| Mar 2, 2026 | Lyons Jonathan M. Sr. Vice President, CFO | Option | 17,937 | — | Form 4 |
| Mar 2, 2026 | Lyons Jonathan M. Sr. Vice President, CFO | Other | 23,988 | $382K | Form 4 |
| Mar 2, 2026 | Lyons Jonathan M. Sr. Vice President, CFO | Other | 8,240 | $131K | Form 4 |
| Mar 2, 2026 | Rutz Michael P President of Sterigenics | Award | 45,223 | — | Form 4 |
| Mar 2, 2026 | Rutz Michael P President of Sterigenics | Option | 14,573 | — | Form 4 |
| Mar 2, 2026 | Rutz Michael P President of Sterigenics | Other | 4,495 | $72K | Form 4 |
| Mar 2, 2026 | Rutz Michael P President of Sterigenics | Other | 17,497 | $278K | Form 4 |
| Dec 8, 2025 | Petras Michael B. Jr. Chairman & CEO · Director | Sale | 394,861 | $6.50M⚡ | Form 4 |
| Dec 8, 2025 | Petras Michael B. Jr. Chairman & CEO · Director | Sale | 39,243 | $646K | Form 4 |
| Aug 22, 2025 | Rutz Michael P President of Sterigenics | Sale | 126,611 | $2.07M⚡ | Form 4 |
| Mar 3, 2025 | Petras Michael B. Jr. Chairman & CEO · Director | Award | 298,953 | — | Form 4 |
| Mar 2, 2025 | Petras Michael B. Jr. Chairman & CEO · Director | Other | 31,872 | $397K | Form 4 |
| Mar 2, 2025 | Petras Michael B. Jr. Chairman & CEO · Director | Other | 40,987 | $511K | Form 4 |
| Mar 3, 2025 | Rutz Michael P President of Sterigenics | Award | 48,579 | — | Form 4 |
| Mar 2, 2025 | Rutz Michael P President of Sterigenics | Other | 4,198 | $52K | Form 4 |
| Mar 2, 2025 | Rutz Michael P President of Sterigenics | Other | 5,399 | $67K | Form 4 |
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Mar 2
股数
39,552
均价
$15.91
总金额
$629K
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Mar 2
股数
40,302
均价
$15.91
总金额
$641K
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Mar 2
股数
79,104
均价
$15.91
总金额
$1.26M ⚡
DIMITRIEF ALEXANDER
SVP, General Counsel and Sec.
日期
Mar 2
股数
23,619
均价
$15.91
总金额
$376K
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Dec 8
股数
394,861
均价
$16.45
总金额
$6.50M ⚡
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Dec 8
股数
39,243
均价
$16.45
总金额
$646K
Rutz Michael P
President of Sterigenics
日期
Aug 22
股数
126,611
均价
$16.38
总金额
$2.07M ⚡
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Mar 2
股数
31,872
均价
$12.47
总金额
$397K
Petras Michael B. Jr.
Chairman & CEO · Director
日期
Mar 2
股数
40,987
均价
$12.47
总金额
$511K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 SHC 内幕交易
SHC 内幕交易
Sotera Health Company(SHC)内幕交易数据来源于公司内部人(包括Petras Michael B. Jr. (Chairman & CEO · Director), Rutz Michael P (President of Sterigenics), Lyons Jonathan M. (Sr. Vice President, CFO))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。SHC内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Sotera Health Company机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
SHC 内幕交易 · 5个问题Sotera Health Company(SHC)的内部人包括高管和董事,如Petras Michael B. Jr. (Chairman & CEO · Director), Rutz Michael P (President of Sterigenics), Lyons Jonathan M. (Sr. Vice President, CFO)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026